Compare iShares MSCI ACWI ETF (ACWI) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI ACWI ETF vs Citius Pharmaceuticals Inc — how do they compare? iShares MSCI ACWI ETF trades at $162, while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: iShares MSCI ACWI ETF is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| ACWI | CTXR | |
|---|---|---|
52-Week High | $161.44 | $1.82 |
52-Week Low | $132.04 | $0.48 |
Market Cap | — | $20.01M |
Sector | — | Health |
Enterprise Value | — | $16.23M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI ACWI ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted market capitalization index designed to measure the combined equity market performance of developed and emerging markets countries.
Read more on ACWI →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
